Lv01
0 积分 2025-06-19 加入
Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies
1小时前
已完结
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
1小时前
已完结
Outcome of temozolomide in relapsed small cell lung cancer: A retrospective single center analysis
2小时前
已完结
Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options
18天前
已完结
The Dual-Response–Single-Amplification Fluorescent Nanomachine for Tumor Imaging and Gastric Cancer Diagnosis
3个月前
已完结
The Dual-Response–Single-Amplification Fluorescent Nanomachine for Tumor Imaging and Gastric Cancer Diagnosis
3个月前
已完结
Elucidating the complexity of radiation-induced brain injury: comprehensive assessment of hippocampal and cortical impacts
3个月前
已完结
Stereotactic ablative radiotherapy and immunotherapy for early-stage lung cancer
3个月前
已完结
Sintilimab combined with anlotinib and chemotherapy as second-line or later therapy in extensive-stage small cell lung cancer: a phase II clinical trial
3个月前
已完结
皖公网安备34019202002308
